‌

US Patent 10155768 Fused pyrimidine compound or salt thereof

Patent 10155768 was granted and assigned to Taiho Pharmaceutical on December, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Taiho Pharmaceutical

0

Current Assignee

Taiho Pharmaceutical

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Isao Miyazaki0

Tadashi Shimamura0

Satoru Iguchi0

Hidenori Fujita0

Masanori Kato0

Date of Patent

December 18, 2018

0

Patent Application Number

157089170

Date Filed

September 19, 2017

0

Patent Citations Received

US Patent 10807986 Fused pyrimidine compound or salt thereof

US Patent 11046696 Fused pyrimidine compound or salt thereof

US Patent 11008324 Fused pyrimidine compound or salt thereof

Patent Primary Examiner

Jeffrey H Murray

0

Patent abstract

The problem to be solved by the present invention is to provide a novel compound having RET inhibitory activity. The present invention also provides a pharmaceutical preparation that is useful for the prevention and/or treatment of RET-related diseases, particularly cancer, based on RET inhibitory activity. The present invention provides a compound represented by Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10155768 Fused pyrimidine compound or salt thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.